We are live on ! Find out more
KBIO

KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO

Delisted

KBIO was delisted on the 16th of December, 2015.

Back to rankings

1 hedge funds and large institutions have $66K invested in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GF
Gerstein Fisher
New York
+$66K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GF
1
Gerstein Fisher
New York
$66K +$66K +20,116 New

KBIO Hedge Fund Activity: Q3 2016 in Review

1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) for Q3 2016, worth a combined $66K.

Buyers outnumbered sellers: 1 fund opened new KBIO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Gerstein Fisher, opening a new position worth an estimated $66K.

  • 1 institutional investor held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) as of Q3 2016, up from 0 in Q2 2016.
  • Funds reported $66K of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) stock for Q3 2016.
  • 1 fund opened new KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) positions in Q3 2016 and 0 closed out, a net change of +1 holder.
  • The largest KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) buyer in Q3 2016 was Gerstein Fisher, an estimated $66K added.

Based on aggregated 13F filings for Q3 2016.